LEIDEN JEFFREY M

CIK 00012428252 companiesBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001242825

Recent Transactions

50 trades

Exercise/Conversion
VERTEX PHARMACEUTICALS INC / MA$VRTX
Stock Option (Right to Buy)
2025-12-04−1→ 0 total
Exercise/Conversion
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2025-12-04$91.05/sh+1→ 24,027 total
Exercise/Conversion
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2025-12-04$91.05/sh+1→ 24,027 total
Exercise/Conversion
VERTEX PHARMACEUTICALS INC / MA$VRTX
Stock Option (Right to Buy)
2025-12-04−1→ 0 total
Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2025-12-03$452.20/sh−15,681→ 36,456 total
Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2025-12-03$451.20/sh−5,809→ 52,137 total
Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2025-12-03$449.84/sh−5,880→ 57,946 total
Exercise/Conversion
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2025-12-03$86.52/sh+63,781→ 87,807 total
Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2025-12-03$440.40/sh−4,469→ 83,338 total
Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2025-12-03$441.26/sh−1,320→ 82,018 total
Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2025-12-03$443.21/sh−2,469→ 79,549 total
Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2025-12-03$444.36/sh−4,352→ 75,197 total
Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2025-12-03$445.56/sh−7,899→ 67,298 total
Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2025-12-03$447.05/sh−1,152→ 66,146 total
Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2025-12-03$448.78/sh−2,320→ 63,826 total
Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2025-12-03$449.84/sh−5,880→ 57,946 total
Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2025-12-03$451.20/sh−5,809→ 52,137 total
Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2025-12-03$452.20/sh−15,681→ 36,456 total
Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2025-12-03$453.34/sh−10,360→ 26,096 total
Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2025-12-03$455.22/sh−2,070→ 24,026 total
Exercise/Conversion
VERTEX PHARMACEUTICALS INC / MA$VRTX
Stock Option (Right to Buy)
2025-12-03−63,781→ 0 total
Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2025-12-03$448.78/sh−2,320→ 63,826 total
Exercise/Conversion
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2025-12-03$86.52/sh+63,781→ 87,807 total
Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2025-12-03$440.40/sh−4,469→ 83,338 total
Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2025-12-03$441.26/sh−1,320→ 82,018 total
Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2025-12-03$443.21/sh−2,469→ 79,549 total
Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2025-12-03$444.36/sh−4,352→ 75,197 total
Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2025-12-03$447.05/sh−1,152→ 66,146 total
Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2025-12-03$445.56/sh−7,899→ 67,298 total
Exercise/Conversion
VERTEX PHARMACEUTICALS INC / MA$VRTX
Stock Option (Right to Buy)
2025-12-03−63,781→ 0 total
Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2025-12-03$455.22/sh−2,070→ 24,026 total
Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2025-12-03$453.34/sh−10,360→ 26,096 total
Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2014-09-30$113.90/sh−41,704→ 144,992 total
Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2014-09-30$112.21/sh−79,817→ 240,446 total
Exercise/Conversion
VERTEX PHARMACEUTICALS INC / MA$VRTX
Stock Option (right to buy)
2014-09-30−200,000→ 213,108 total
Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2014-09-30$113.10/sh−53,750→ 186,696 total
Exercise/Conversion
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2014-09-30$29.98/sh+200,000→ 344,992 total
Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2014-09-30$111.31/sh−24,729→ 320,263 total
Tax Payment
ABBOTT LABORATORIES$ABT
Common shares without par value
2005-07-01$49.30/sh−31,923→ 296,054 total
Tax Payment
ABBOTT LABORATORIES$ABT
Common shares without par value
2005-07-01$49.30/sh−31,923→ 296,054 total
Exercise/Conversion
ABBOTT LABORATORIES$ABT
Option (right to buy)
2005-06-07−24,629→ 424,421 total
Exercise/Conversion
ABBOTT LABORATORIES$ABT
Common shares without par value
2005-06-07$33.23/sh+24,629→ 347,921 total
Award
ABBOTT LABORATORIES$ABT
Option (right to buy)
2005-06-07+19,944→ 19,944 total
Tax Payment
ABBOTT LABORATORIES$ABT
Common shares without par value
2005-06-07$48.45/sh−19,944→ 327,977 total
Exercise/Conversion
ABBOTT LABORATORIES$ABT
Common shares without par value
2005-06-07$33.23/sh+24,629→ 347,921 total
Tax Payment
ABBOTT LABORATORIES$ABT
Common shares without par value
2005-06-07$48.45/sh−19,944→ 327,977 total
Exercise/Conversion
ABBOTT LABORATORIES$ABT
Option (right to buy)
2005-06-07−24,629→ 424,421 total
Award
ABBOTT LABORATORIES$ABT
Option (right to buy)
2005-06-07+19,944→ 19,944 total
Exercise/Conversion
ABBOTT LABORATORIES$ABT
Common shares without par value
2004-09-01$33.23/sh+15,469→ 290,461 total
Tax Payment
ABBOTT LABORATORIES$ABT
Common shares without par value
2004-09-01$41.69/sh−13,569→ 276,892 total

Companies

Recent Filings

4
LEIDEN JEFFREY M
Dec 5, 2025

Address

C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE

BOSTON, MA, 02210

View on SEC.gov